Name Net reduced
positions
Reduced positions Increased positions Return since
31 Mar ‘22
151
8 23 15 21.3%
152
8 22 14 90.8%
153
8 12 4 35.9%
SPRO icon
154
Spero Therapeutics
SPRO
$162M
8 23 15 67.8%
155
7 22 15 79.3%
156
7 16 9 36.3%
157
7 10 3 78.6%
158
7 12 5 89.6%
159
7 12 5 75.5%
160
7 18 11 33.1%
IDNA icon
161
iShares Genomics Immunology and Healthcare ETF
IDNA
$162M
7 29 22 12.1%
162
7 19 12 4.2%
163
7 34 27 87.3%
164
7 55 48 96.6%
165
7 47 40 48%
166
7 10 3 16.3%
167
7 18 11 1.42%
168
7 15 8 41.3%
169
7 10 3 1.63%
170
7 22 15 35.7%
171
7 8 1 81.7%
172
7 8 1 82.7%
173
7 16 9 98.5%
174
7 15 8 31.3%
175
7 14 7 97.2%